Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00132704 · ClinicalTrials.gov registry record

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
149
Enrollment target

NCT00132704: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00132704 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00132704 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
149 participants
Enrollment target

Study Summary

Doctors will take some tissue from the tissue removed during surgery in order to study how the blood vessels of the tumor respond to radiation therapy. The tissue obtained will be used to determine how these tumor blood vessels respond to radiation therapy delivered to the tumor, after it has been removed. This radiation is delivered in the research lab. This research is being conducted in order to develop new methods to treat tumors by radiation therapy. No additional surgery will be performed to obtain these samples, and only materials that remain after all diagnostic testing has been completed will be used.

Primary Outcome

The peak apoptotic radiation response will be obtained for each of the tumor type and the result compared to that of the mouse experiments in Garcia-Barros (no formal testing only qualitative statements).

Interventions

  • RADIATION Ionizing radiation (IR) therapy
  • RADIATION Ionizing radiation (IR)

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2004-08
Est. Completion 2014-07
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00132704 record still lists

NCT00132704 is an observational study that tracks outcomes without assigning an intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Ionizing radiation (IR) therapy is the first listed.

NCT00132704 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00132704 about?

NCT00132704 is a clinical study titled "An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation". Doctors will take some tissue from the tissue removed during surgery in order to study how the blood vessels of the tumor respond to radiation therapy. The tissue obtained will be used to determine how these tumor blood vessels respond to radiation therapy delivered to the tumor, after it has been r...

What is the current status of trial NCT00132704?

This trial is currently completed. The enrollment target is 149 participants. The study started on 2004-08. Estimated completion is 2014-07.

What interventions are being tested in trial NCT00132704?

The interventions under investigation include: Ionizing radiation (IR) therapy (RADIATION), Ionizing radiation (IR) (RADIATION).

Who is sponsoring clinical trial NCT00132704?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00132704, the US trial registry maintained by the National Library of Medicine. NCT00132704 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.